← Back to Search

Machine Learning

HindSight for Staphylococcal Sepsis (HindSight P2 Trial)

Phase 2
Waitlist Available
Led By Ritankar Das, MSc
Research Sponsored by Dascena
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* During the study period, all patients over the age of 18 presenting to the emergency department or admitted to an inpatient unit at the participating facilities will automatically be enrolled in the study, until the enrollment target for the study is met
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, human subjects involvement will occur for an average of eight months
Awards & highlights
No Placebo-Only Group

Summary

This trial will test whether a machine-learning-based CDS tool for sepsis alerts, called InSight, is more accurate when its labels are created by a software called HindSight.

Eligible Conditions
  • Staphylococcal Sepsis
  • Sepsis

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, human subjects involvement will occur for an average of eight months
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, human subjects involvement will occur for an average of eight months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Rate of reduction in false alerts

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: ExperimentalExperimental Treatment1 Intervention
The experimental arm will involve patients monitored by HindSight.
Group II: ControlActive Control1 Intervention
The control arm will involve patients monitored by InSight.

Find a Location

Who is running the clinical trial?

DascenaLead Sponsor
13 Previous Clinical Trials
130,061 Total Patients Enrolled
Cape Regional Medical CenterUNKNOWN
Cooper University Medical CenterUNKNOWN
~9303 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top